Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.67

-2.3%

11:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8885)	7/30/2003 6:46:53 AM
From: dalroi	of 52153

I had a talk yesterday with aksy cfo ? very informative he said : 1/ cost reduction is on tract old machine 60k new (secund h 2003)is 45k primarily due to using other materials so no new fda clearance needed 2/ no change in sales forcast (oef) 3/ ongoing talk with the large dialysis centers 4/ talking with lawyers of the co to see best way out of this mess , poison pill could dilute durus holdings but not the other shareholders 5/ Scott Sacane cant sell now because then his gains should go to the co rules 16B so either durus sells its holdings and pays the co the profit (their cost base should be around 8) or they get diluted out IMO Perhaps it could be a win no loss situation suppose the agree on the following Durus sells stock and gives gains to the co , co temporaily suspends poison pill to give durus a way out, and they wait/forget to announce it till durus cut its holdings back RESULT co gets free cash without issuing new shares Durus gets out without loosing its pants in the dillution comments appreciated Stefaan ps He called back when i was already a sleep , had to jumpstart brain so i hope i got it right (last part is pure speculation of mine )

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next